|
1
|
Wimberger P, Lehmann N, Kimmig R, Burges
A, Meier W, Hoppenau B and du Bois A: AGO-OVAR: Impact of age on
outcome in patients with advanced ovarian cancer treated within a
prospectively randomized phase III study of the arbeitsgemeinschaft
gynaekologische onkologie ovarian cancer study group (AGO-OVAR).
Gynecol Oncol. 100:300–307. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martins FC, Couturier DL, Paterson A,
Karnezis AN, Chow C, Nazeran TM, Odunsi A, Gentry-Maharaj A, Vrvilo
A, Hein A, et al: Clinical and pathological associations of PTEN
expression in ovarian cancer: A multicentre study from the ovarian
tumour tissue analysis consortium. Br J Cancer. 123:793–802. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Courtney-Brooks M, Tellawi AR, Scalici J,
Duska LR, Jazaeri AA, Modesitt SC and Cantrell LA: Frailty: An
outcome predictor for elderly gynecologic oncology patients.
Gynecol Oncol. 126:20–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anic K, Birkert S, Schmidt MW, Linz VC,
Heimes AS, Krajnak S, Schwab R, Schmidt M, Westphalen C, Hartmann
EK, et al: G-8 geriatric screening tool independently predicts
progression-free survival in older ovarian cancer patients
irrespective of maximal surgical effort: Results of a retrospective
cohort study. Gerontology. 1–10. 2021.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gibson SJ, Fleming GF, Temkin SM and Chase
DM: The application and outcome of standard of care treatment in
elderly women with ovarian cancer: A literature review over the
last 10 years. Front Oncol. 6:632016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fotopoulou C, Planchamp F, Aytulu T, Chiva
L, Cina A, Ergönül Ö, Fagotti A, Haidopoulos D, Hasenburg A, Hughes
C, et al: European society of gynaecological oncology guidelines
for the peri-operative management of advanced ovarian cancer
patients undergoing debulking surgery. Int J Gynecol Cancer.
31:1199–1206. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Landrum LM, Java J, Mathews CA, Lanneau GS
Jr, Copeland LJ, Armstrong DK and Walker JL: Prognostic factors for
stage III epithelial ovarian cancer treated with intraperitoneal
chemotherapy: A gynecologic oncology group study. Gynecol Oncol.
130:12–18. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsuchiya Y, Sawada S, Yoshioka I, Ohashi
Y, Matsuo M, Harimaya Y, Tsukada K and Saiki I: Increased surgical
stress promotes tumor metastasis. Surgery. 133:547–555. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eschwège P, Dumas F, Blanchet P, Le Maire
V, Benoit G, Jardin A, Lacour B and Loric S: Haematogenous
dissemination of prostatic epithelial cells during radical
prostatectomy. Lancet. 346:1528–1530. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hiller JG, Perry NJ, Poulogiannis G,
Riedel B and Sloan EK: Perioperative events influence cancer
recurrence risk after surgery. Nat Rev Clin Oncol. 15:205–218.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bar-Yosef S, Melamed R, Page GG, Shakhar
G, Shakhar K and Ben-Eliyahu S: Attenuation of the tumor-promoting
effect of surgery by spinal blockade in rats. Anesthesiology.
94:1066–1073. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen XB, Zhang HL and Fang XD:
Surgery-induced immunomodulation in breast cancer. J Surg Oncol.
103:197author reply 196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rao VS, Dyer CE, Jameel JK, Drew PJ and
Greenman J: Potential prognostic and therapeutic roles for
cytokines in breast cancer (Review). Oncol Rep. 15:179–185.
2006.PubMed/NCBI
|
|
16
|
Pei L, Tan G, Wang L, Guo W, Xiao B, Gao
X, Wang L, Li H, Xu Z, Zhang X, et al: Comparison of combined
general-epidural anesthesia with general anesthesia effects on
survival and cancer recurrence: A meta-analysis of retrospective
and prospective studies. PLoS One. 9:e1146672014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reed N, Balega J, Barwick T, Buckley L,
Burton K, Eminowicz G, Forrest J, Ganesan R, Harrand R, Holland C,
et al: British Gynaecological cancer society (BGCS) cervical cancer
guidelines: Recommendations for practice. Eur J Obstet Gynecol
Reprod Biol. 256:433–465. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brittenden J, Heys SD, Ross J and Eremin
O: Natural killer cells and cancer. Cancer. 77:1226–1243. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Snyder GL and Greenberg S: Effect of
anaesthetic technique and other perioperative factors on cancer
recurrence. Br J Anaesth. 105:106–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cummings KC III, Xu F, Cummings LC and
Cooper GS: A comparison of epidural analgesia and traditional pain
management effects on survival and cancer recurrence after
colectomy: A population-based study. Anesthesiology. 116:797–806.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gottschalk A, Ford JG, Regelin CC, You J,
Mascha EJ, Sessler DI, Durieux ME and Nemergut EC: Association
between epidural analgesia and cancer recurrence after colorectal
cancer surgery. Anesthesiology. 113:27–34. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kawaraguchi Y, Horikawa YT, Murphy AN,
Murray F, Miyanohara A, Ali SS, Head BP, Patel PM, Roth DM and
Patel HH: Volatile anesthetics protect cancer cells against tumor
necrosis factor-related apoptosis-inducing ligand-induced apoptosis
via caveolins. Anesthesiology. 115:499–508. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yeager MP, Colacchio TA, Yu CT,
Hildebrandt L, Howell AL, Weiss J and Guyre PM: Morphine inhibits
spontaneous and cytokine-enhanced natural killer cell cytotoxicity
in volunteers. Anesthesiology. 83:500–508. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singleton PA, Moss J, Karp DD, Atkins JT
and Janku F: The mu opioid receptor: A new target for cancer
therapy? Cancer. 121:2681–2688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Guo W, Wu Q, Zhang R and Fang J:
Impact of combination epidural and general anesthesia on the
long-term survival of gastric cancer patients: A retrospective
study. Med Sci Monit. 22:2379–2385. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Colombo N, Peiretti M, Parma G, Lapresa M,
Mancari R, Carinelli S, Sessa C and Castiglione M; ESMO Guidelines
Working Group, : Newly diagnosed and relapsed epithelial ovarian
carcinoma: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 21 (Suppl 5):v23–v30. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sundararajan V, Henderson T, Perry C,
Muggivan A, Quan H and Ghali WA: New ICD-10 version of the Charlson
comorbidity index predicted in-hospital mortality. J Clin
Epidemiol. 57:1288–1294. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
D'Hoore W, Bouckaert A and Tilquin C:
Practical considerations on the use of the Charlson comorbidity
index with administrative data bases. J Clin Epidemiol.
49:1429–1433. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Davenport DL, Bowe EA, Henderson WG, Khuri
SF and Mentzer RM Jr: National surgical quality improvement program
(NSQIP) risk factors can be used to validate American Society of
anesthesiologists physical status classification (ASA PS) levels.
Ann Surg. 243:636–41; discussion 641-4. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aletti GD, Dowdy SC, Podratz KC and Cliby
WA: Relationship among surgical complexity, short-term morbidity,
and overall survival in primary surgery for advanced ovarian
cancer. Am J Obstet Gynecol. 197:676e1–e7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eger EI II, Saidman LJ and Brandstater B:
Minimum alveolar anesthetic concentration: A standard of anesthetic
potency. Anesthesiology. 26:756–763. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Campagna JA, Miller KW and Forman SA:
Mechanisms of actions of inhaled anesthetics. N Engl J Med.
348:2110–2124. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuniyoshi H, Yamamoto Y, Kimura S, Hiroe
T, Terui T and Kase Y: Comparison of the analgesic effects
continuous epidural anesthesia and continuous rectus sheath block
in patients undergoing gynecological cancer surgery: A
non-inferiority randomized control trial. J Anesth. 35:663–670.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhong S, Zhong X, Zhong X and Liu Y:
Comparison between the effect of epidural anesthesia combined with
epidural analgesia and general anesthesia combined with intravenous
analgesia on prognosis of ovarian cancer patients. Oncol Lett.
17:5662–5668. 2019.PubMed/NCBI
|
|
35
|
Tseng JH, Cowan RA, Afonso AM, Zhou Q,
Iasonos A, Ali N, Thompson E, Sonoda Y, O'Cearbhaill RE, Chi DS, et
al: Perioperative epidural use and survival outcomes in patients
undergoing primary debulking surgery for advanced ovarian cancer.
Gynecol Oncol. 151:287–293. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin L, Liu C, Tan H, Ouyang H, Zhang Y and
Zeng W: Anaesthetic technique may affect prognosis for ovarian
serous adenocarcinoma: A retrospective analysis. Br J Anaesth.
106:814–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
de Oliveira GS Jr, Ahmad S, Schink JC,
Singh DK, Fitzgerald PC and McCarthy RJ: Intraoperative neuraxial
anesthesia but not postoperative neuraxial analgesia is associated
with increased relapse-free survival in ovarian cancer patients
after primary cytoreductive surgery. Reg Anesth Pain Med.
36:271–277. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lacassie HJ, Cartagena J, Brañes J, Assel
M and Echevarría GC: The relationship between neuraxial anesthesia
and advanced ovarian cancer-related outcomes in the Chilean
population. Anesth Analg. 117:653–660. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Capmas P, Billard V, Gouy S, Lhommé C,
Pautier P, Morice P and Uzan C: Impact of epidural analgesia on
survival in patients undergoing complete cytoreductive surgery for
ovarian cancer. Anticancer Res. 32:1537–1542. 2012.PubMed/NCBI
|
|
40
|
Cakmakkaya OS, Kolodzie K, Apfel CC and
Pace NL: Anaesthetic techniques for risk of malignant tumour
recurrence. Cochrane Database Syst Rev. ((11)):
CD0088772014.PubMed/NCBI
|
|
41
|
Bartal I, Melamed R, Greenfeld K, Atzil S,
Glasner A, Domankevich V, Naor R, Beilin B, Yardeni IZ and
Ben-Eliyahu S: Immune perturbations in patients along the
perioperative period: Alterations in cell surface markers and
leukocyte subtypes before and after surgery. Brain Behav Immun.
24:376–386. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li JM, Shao JL, Zeng WJ and Liang RB:
General/epidural anesthesia in combination preserves NK cell
activity and affects cytokine response in cervical carcinoma
patients undergoing radical resection: A cohort prospective study.
Eur J Gynaecol Oncol. 36:703–707. 2015.PubMed/NCBI
|
|
43
|
Shavit Y, Ben-Eliyahu S, Zeidel A and
Beilin B: Effects of fentanyl on natural killer cell activity and
on resistance to tumor metastasis in rats. Neuroimmunomodulation.
11:255–260. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vergote I, Tropé CG, Amant F, Kristensen
GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ,
Panici PB, et al: Neoadjuvant chemotherapy or primary surgery in
stage IIIC or IV ovarian cancer. N Engl J Med. 363:943–953. 2010.
View Article : Google Scholar : PubMed/NCBI
|
